2min chapter

Business Of Biotech cover image

T-Cells For The Win With Adaptimmune's Adrian Rawcliffe

Business Of Biotech

CHAPTER

The Future of T-Cell Therapies and Genericization Challenges

This chapter discusses the challenges and potential of T-cell therapies in comparison to traditional monoclonal antibodies, focusing on patenting and manufacturing issues. It highlights the promise of generics and biosimilars in the industry while forecasting advancements in regulatory frameworks for improved access to these biopharmaceuticals.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode